This study randomly assigned 114 participants with significant fear of heights to one of three conditions: a) a single session of virtual reality exposure; b) a single session of in vivo exposure; or c) a control condition. The aim of this study was to compare the efficacy of virtual reality exposure to the efficacy of in vivo exposure or no exposure for participants with significant fear of heights.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Acrophobia Questionnaire (AQ)
Timeframe: Immediately Post-Treatment (Controlling for Baseline Scores)
Behavioral Approach Task (BAT)
Timeframe: Immediately Post-Treatment (Controlling for Baseline Scores)
Heights Interpretation Questionnaire (HIQ)
Timeframe: Immediately Post-Treatment (Controlling for Baseline Scores)
Acrophobia Questionnaire (AQ)
Timeframe: 1-Week Post-Treatment (Controlling for Immediate Post-Treatment Scores)
Behavioral Approach Task (BAT)
Timeframe: 1-Week Post-Treatment (Controlling for Immediate Post-Treatment Scores)
Heights Interpretation Questionnaire (HIQ)
Timeframe: 1-Week Post-Treatment (Controlling for Immediate Post-Treatment Scores)